Gastroesophageal reflux disease as a risk factor of dental hard tissues erosions

O. O. Yanushevich, I. Maev, N. I. Krikheli, P. S. Sokolov, D. N. Andreev, M. Bychkova, E. G. Lobanova, M. Y. Starovoytova
{"title":"Gastroesophageal reflux disease as a risk factor of dental hard tissues erosions","authors":"O. O. Yanushevich, I. Maev, N. I. Krikheli, P. S. Sokolov, D. N. Andreev, M. Bychkova, E. G. Lobanova, M. Y. Starovoytova","doi":"10.21518/ms2024-234","DOIUrl":null,"url":null,"abstract":"Gastroesophageal reflux disease (GERD) is a common chronic disease leading to a spontaneous and regular retrograde flow of gastric and/or duodenal contents into the esophagus. Reflux of the gastric contents into the oral cavity refers to the extraesophageal presentation of the disease, which, in the absence of timely treatment, can result in erosion of dental hard tissue (EDHT) through repeated exposure of the dental tissue to acidic contents. EDHT are non-carious lesions of the dental hard tissues (mainly enamel, and in some cases dentin), induced by a chemical reaction involving acids, which results in demineralization processes. The incidence rates of EDHT in adult patients with GERD are 32.5–51.5%. The EDHT in GERD develops in stages. Initially, the gradual degradation of tooth pelicula happens when it gradually becomes decayed by repeated acidic attacks. The loss of the pelicula results in direct contact of hydrochloric acid refluxate with the enamel surface and initiation of its demineralization at pH < 5.5 with dissolution of hydroxyapatite crystals. Given the high prevalence of GERD in the population, it seems important to update an integrated approach to the treatment of such patients, which involves pharmacotherapy provided by the gastroenterologist, as well as prevention and minimally invasive treatment of presentations in the oral cavity by the dentist. Patients with EDHT due to GERD need to maintain individual oral hygiene (use mouth washes with a neutral pH level, avoid abrasive toothpastes), use remineralization therapy at home applying remogels (Tooth Mousse), and also be observed by a dentist as part of the follow-up care. Minimally invasive treatment by the dentist involves restorations using composite tooth filling materials and ceramic veneers. It is reasonable to empirically use proton pump inhibitors twice a day for 3 months for the direct treatment of GERD in patients with EDHT.","PeriodicalId":18391,"journal":{"name":"Meditsinskiy sovet = Medical Council","volume":"9 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Meditsinskiy sovet = Medical Council","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21518/ms2024-234","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Gastroesophageal reflux disease (GERD) is a common chronic disease leading to a spontaneous and regular retrograde flow of gastric and/or duodenal contents into the esophagus. Reflux of the gastric contents into the oral cavity refers to the extraesophageal presentation of the disease, which, in the absence of timely treatment, can result in erosion of dental hard tissue (EDHT) through repeated exposure of the dental tissue to acidic contents. EDHT are non-carious lesions of the dental hard tissues (mainly enamel, and in some cases dentin), induced by a chemical reaction involving acids, which results in demineralization processes. The incidence rates of EDHT in adult patients with GERD are 32.5–51.5%. The EDHT in GERD develops in stages. Initially, the gradual degradation of tooth pelicula happens when it gradually becomes decayed by repeated acidic attacks. The loss of the pelicula results in direct contact of hydrochloric acid refluxate with the enamel surface and initiation of its demineralization at pH < 5.5 with dissolution of hydroxyapatite crystals. Given the high prevalence of GERD in the population, it seems important to update an integrated approach to the treatment of such patients, which involves pharmacotherapy provided by the gastroenterologist, as well as prevention and minimally invasive treatment of presentations in the oral cavity by the dentist. Patients with EDHT due to GERD need to maintain individual oral hygiene (use mouth washes with a neutral pH level, avoid abrasive toothpastes), use remineralization therapy at home applying remogels (Tooth Mousse), and also be observed by a dentist as part of the follow-up care. Minimally invasive treatment by the dentist involves restorations using composite tooth filling materials and ceramic veneers. It is reasonable to empirically use proton pump inhibitors twice a day for 3 months for the direct treatment of GERD in patients with EDHT.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
胃食管反流病是牙齿硬组织侵蚀的危险因素之一
胃食管反流病(GERD)是一种常见的慢性疾病,会导致胃和/或十二指肠内容物自发地、有规律地逆流进入食管。胃内容物反流到口腔是指疾病在食管外的表现,如果没有及时治疗,牙齿组织反复暴露在酸性内容物中,可能导致牙齿硬组织侵蚀(EDHT)。牙齿硬组织侵蚀是牙齿硬组织(主要是牙釉质,有时也包括牙本质)的非龋性病变,由酸性物质引起的化学反应导致脱矿过程。患有胃食管反流病的成年患者中,EDHT 的发病率为 32.5%-51.5%。胃食管反流病的 EDHT 是分阶段发展的。起初,当牙齿受到反复酸性侵蚀而逐渐腐烂时,牙釉质会逐渐退化。牙釉质的脱落导致盐酸回流液与牙釉质表面直接接触,在 pH 值小于 5.5 时,随着羟基磷灰石晶体的溶解,牙釉质开始脱矿。鉴于胃食管反流病在人群中的高发病率,更新治疗这类患者的综合方法似乎非常重要,其中包括由胃肠病学家提供药物治疗,以及由牙科医生对口腔病变进行预防和微创治疗。因胃食管反流而患有 EDHT 的患者需要保持个人口腔卫生(使用 pH 值为中性的漱口水,避免使用磨蚀性牙膏),在家中使用再矿化疗法,涂抹再矿化凝胶(牙齿摩丝),并由牙医进行观察,作为后续护理的一部分。牙医的微创治疗包括使用复合牙填充材料和陶瓷贴面进行修复。经验性使用质子泵抑制剂直接治疗胃食管反流病患者的胃食管反流病是合理的,每天两次,连续使用 3 个月。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical and pathogenetic features of thyropathies diagnosed during the post-COVID-19 period Lung cancer associated with an activating mutation in the 14th exon of the MET gene Immune Checkpoint Inhibitors in first versus second line of metastatic non-small cell lung cancer: Real-World Overall Survival Second-generation tyrosine kinase inhibitors in chronic myeloid leukemia today: efficacy and safety Experience with the use of nivolumab and ipilimumab in metastatic fibrolamellar liver carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1